No results for ‘’
Ipca Laboratories Ltd
₹1968.50
(0.12%)
Sun, 13 Sept 2026, 09:08 am
Health Technology
Pharmaceuticals: Major
24.5KIpca Laboratories Share Price Live Chart
1 Day
(0.12%)
No Result Found
Summary
Market Cap (in Cr)
38382.91
Net Profit (in Cr)
787.53
P/B
5.48
Sector P/E
33.76
P/E
51.63
EV/EBITDA
24.19
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
13.61
ROCE
17.12
Debt/Equity
0.21
EPS (TTM)
41.57
Dividend Yield
0.26
Book Value
292.74
Interest Cover
15.85
Analysis
all
- Ipca Laboratories's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Ipca Laboratories's earnings are expected to exceed the low risk growth rate next year.
- Performance (ROE) is expected to be above the current IN Pharmaceuticals industry average.
- An improvement in Ipca Laboratories's performance (ROE) is expected over the next 3 years.
- Ipca Laboratories's revenue growth is expected to exceed the India market average.
- Ipca Laboratories is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Ipca Laboratories's dividends as it is not paying a notable one for India.
- No need to calculate the sustainability of Ipca Laboratories's dividends in 3 years as they are not expected to pay a notable one for India.
- Ipca Laboratories is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Ipca Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 44.72 | 44.72 | 44.72 | 44.72 | 44.72 |
| FII | 10.63 | 10.63 | 10.42 | 10.67 | 10.76 |
| DII | 37.45 | 37.32 | 36.77 | 36.20 | 36.06 |
| Public | 7.20 | 7.33 | 8.08 | 8.40 | 8.46 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2515.63 | 2198.03 | 2086.47 | 1880.43 | 1768.87 | 1562.83 | 1245.23 |
| Fibonacci | 2198.03 | 2076.71 | 2001.76 | 1880.43 | 1759.11 | 1684.16 | 1562.83 |
| Camarilla | 2062.24 | 2033.13 | 2004.01 | 1880.43 | 1945.79 | 1916.67 | 1887.56 |
Pivots Level: Classic
R3
+635.20
2515.63
R2
+317.60
2198.03
R1
+206.03
2086.47
S1
-111.57
1768.87
S2
-317.60
1562.83
S3
-635.20
1245.23
Moving Average
Period
Value
10-EMA
1958.78
20-EMA
1928.45
30-EMA
1897.76
50-EMA
1844.97
100-EMA
1749.27
200-EMA
1641.26
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 May 2026 | board-meetings | Accounts, Dividend | |
| 13 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 11 Jul 2025 | agm | ||
| 05 Jul 2025 | dividend | Final Dividend - Rs. - 2 | 05 Aug 2025 |
| 29 May 2025 | dividend | ₹2.00 Dividend /Share | 05 Aug 2025 |
| 14 Nov 2024 | dividend | ₹2.00 Dividend /Share | 27 Nov 2024 |
| 27 Oct 2024 | dividend | Interim Dividend - Rs. - 2 | 27 Nov 2024 |
| 17 Jul 2024 | agm | ||
| 06 Jul 2024 | dividend | Annual General Meeting/Dividend - Rs 2 Per Share | 07 Aug 2024 |
Peer Comparison
Ipca Laboratories Ltd
Cipla Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Ipca Laboratories Ltd About
Ipca Laboratories is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical Ingredients (APIs). The Company is an integrated pharmaceutical company manufacturing and marketing.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1949
Headquarters
CEO
Premchand Godha
Employees
Contact
Website
http://www.ipca.com
investors@ipca.com ; ipca@ipca.com
Phone
91-22-66474444
Location
48 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| USHA MADHUKAR CHANDURKAR | bulk | Sell | 4000000 | 1501.52 | 18 Dec 2024 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 158841 | 867.55 | 14 Nov 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 158841 | 867.55 | 14 Nov 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 158842 | 927.15 | 03 Nov 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 158842 | 927.15 | 03 Nov 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 68372 | 900.35 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 148105 | 900.35 | 25 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 148105 | 900.35 | 25 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 68372 | 900.35 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 232725 | 889.45 | 17 Oct 2022 |
Frequently Asked Questions
1.What is the stock price of Ipca Laboratories Ltd?
As of 13/09/2026 at 2:38 PM, Ipca Laboratories Ltd shares are trading at ₹1968.50.
2.What is the market cap. of Ipca Laboratories Ltd?
As of 13/09/2026, the market capitalization of Ipca Laboratories Ltd is ₹49,973.40 crore.
3.When was Ipca Laboratories Ltd founded?
Ipca Laboratories Ltd was founded in 1949.
4.What are the P/E and P/B ratios of Ipca Laboratories Ltd?
As of 13/09/2026, Ipca Laboratories Ltd has a P/E ratio of 38.13 and a P/B ratio of 5.48.
5.How can I buy shares of Ipca Laboratories Ltd?
You can buy shares of Ipca Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Ipca Laboratories Ltd?
As of March,2026, promoters hold 44.72% in Ipca Laboratories Ltd, while FIIs, DIIs and public shareholders hold 10.63%, 37.45% and 7.20%, respectively.
7.Does Ipca Laboratories Ltd pay dividends?
Yes, Ipca Laboratories Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 2 per share.
8.What is the dividend yield of Ipca Laboratories Ltd?
As of 13 September, 2026, the dividend yield of Ipca Laboratories Ltd stands at 0.30%.
9.What are the latest financial results of Ipca Laboratories Ltd?
For January,2024, Ipca Laboratories Ltd reported revenue of ₹8,849.00 crore and a net profit of ₹738.00 crore.
10.What is the Stock symbol of Ipca Laboratories Ltd?
IPCALAB is the stock symbol of Ipca Laboratories Ltd.
11.Who is the CEO of Ipca Laboratories Ltd?
The CEO of Ipca Laboratories Ltd is Premchand Godha.